Living Donation Week 2020 – Spotlight Session: Dr. Nazia Selzner
Do not miss Dr. Nazia Selzner‘s sessions at the Living Donation Week 2020: “Improving Access to Liver Transplantation in Diverse Communities” and “The Future of Transplantation and Living donation.”
Dr. Nazia Selzner is a Transplant Hepatologist and Medical Director of Live Donor Liver Transplantation in the Multi-Organ Transplant Program, University Health Network, and Associate Professor of Medicine at the University of Toronto. Dr. Nazia Selzner is a Scientist at the Institute for Medical Science (IMS) as well as at the Toronto General Research Institute (TGRI). Dr. Selzner graduated from Medical School at the University of Paris VII, France and completed her Gastroenterology training in 1998. She completed her PhD in 2003 at the University of Paris VII, France, after four years of research fellowship at Duke University Medical Center, Durham, NC and at the University of Zurich, Switzerland. Her research interest is in the mechanism of ischemia/reperfusion injury of the liver. Her interest in ischemia and reperfusion injury started during her research fellowship at Duke University where she studied mechanisms of reperfusion injury in diseased livers, such as steatotic or aging livers. She continued her research in this field in Toronto. Dr. Selzner has recently received the Canadian Society of Transplantation Research Excellence Award.
Access LT: Improving Access to Liver Transplantation in Diverse Communities
Tuesday, September 15 at 8:30am ET
Over the past two decades the incidence and prevalence of cirrhosis has increased substantially, reaching approximately 1% of the population of Ontario and possibly Canada. This number is projected to increase significantly over the next 20 years as the twin epidemics of non-alcoholic fatty liver disease (NAFLD) and alcohol-related disease (ALD) grow.
Despite increasing need for liver transplantation, access to liver transplant or living donation is not equal across various ethnoracial communities. Many patients with liver disease do not receive a timely diagnosis or a referral for liver transplantation. Others will never receive a live-saving transplantation due to lack of an available organ or an appropriate match. Many are not aware or unsure about living organ donation or transplantation.
Very little research has been undertaken on liver disease, organ donation and liver transplantation in immigrant and ethno-racial minority communities in Canada and elsewhere. The ACCESS LT project will document the prevalence of liver disease, barriers to access to care, and ways to improve living liver donation and transplantation rates in immigrant and ethnic and racial minority communities. Phase 1 of the project, funded by CDTRP, will undertake a comprehensive epidemiological study of liver disease and living liver donation and transplantation in immigrant and ethno-racial communities in Ontario/Canada.
This webinar will present preliminary data from the newly launched ACCESS LT project along with the experiences of patients and practitioners serving the diverse Chinese and South Asian communities in Ontario.
Thought Leadership Panel: The Future of Transplantation and Living donation
Wednesday, September 16 at 8:30am ET
Join this session on the future of transplantation and living donation moderated by André Picard from the Globe and Mail.